Immune checkpoints expressed in active, non-segmental vitiligo
Two immune checkpoints, Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) and programmed death-1 (PD-1), appear to be present in the infl
Immune checkpoints expressed in active, non-segmental vitiligo
Isotretinoin use may reduce vitiligo risk
Skin cancer risk for patients with vitiligo does not increase after UVB phototherapy
Ruxolitinib shows positive results for the treatment of vitiligo
Dermatologists share skin care tips for those with vitiligo
NBUVB Therapy Safe and Effective for Some Skin Conditions
Long-lasting vitiligo improvement with IL-15 blockade
Skin colour of patients with vitiligo restored using arthritis medication, UVB light